• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于筛查史的风险分层:NELSON 肺癌筛查研究。

Risk stratification based on screening history: the NELSON lung cancer screening study.

机构信息

Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Thorax. 2017 Sep;72(9):819-824. doi: 10.1136/thoraxjnl-2016-209892. Epub 2017 Mar 30.

DOI:10.1136/thoraxjnl-2016-209892
PMID:28360223
Abstract

BACKGROUND

Debate about the optimal lung cancer screening strategy is ongoing. In this study, previous screening history of the Dutch-Belgian Lung Cancer Screening trial (NELSON) is investigated on if it predicts the screening outcome (test result and lung cancer risk) of the final screening round.

METHODS

15 792 participants were randomised (1:1) of which 7900 randomised into a screening group. CT screening took place at baseline, and after 1, 2 and 2.5 years. Initially, three screening outcomes were possible: negative, indeterminate or positive scan result. Probability for screening outcome in the fourth round was calculated for subgroups of participants.

RESULTS

Based on results of the first three rounds, three subgroups were identified: (1) those with exclusively negative results (n=3856; 73.0%); (2) those with ≥1 indeterminate result, but never a positive result (n=1342; 25.5%); and (3) with ≥1 positive result (n=81; 1.5%). Group 1 had the highest probability for having a negative scan result in round 4 (97.2% vs 94.8% and 90.1%, respectively, p<0.001), and the lowest risk for detecting lung cancer in round 4 (0.6% vs 1.6%, p=0.001). 'Smoked pack-years' and 'screening history' significantly predicted the fourth round test result. The third round results implied that the risk for detecting lung cancer (after an interval of 2.5 years) was 0.6% for those with negative results compared with 3.7% of those with indeterminate results.

CONCLUSIONS

Previous CT lung cancer screening results provides an opportunity for further risk stratifications of those who undergo lung cancer screening.

TRIAL REGISTRATION NUMBER

Results, ISRCTN63545820.

摘要

背景

关于最佳肺癌筛查策略的争论仍在继续。本研究旨在探讨荷兰-比利时肺癌筛查试验(NELSON)的既往筛查史是否能预测最终筛查轮次的筛查结果(检查结果和肺癌风险)。

方法

共有 15792 名参与者被随机分配(1:1),其中 7900 名被随机分配至筛查组。CT 筛查在基线、1、2 和 2.5 年后进行。最初,可能出现三种筛查结果:阴性、不确定或阳性扫描结果。计算了第四轮筛查中各亚组的筛查结果概率。

结果

基于前三轮结果,确定了三个亚组:(1)结果均为阴性者(n=3856;73.0%);(2)有≥1 次不确定结果,但从未有阳性结果者(n=1342;25.5%);(3)有≥1 次阳性结果者(n=81;1.5%)。第 1 组在第 4 轮出现阴性扫描结果的概率最高(97.2%对 94.8%和 90.1%,p<0.001),第 4 轮检测出肺癌的风险最低(0.6%对 1.6%,p=0.001)。“吸烟包年数”和“筛查史”显著预测了第 4 轮检查结果。第 3 轮结果表明,阴性结果者检测出肺癌的风险(间隔 2.5 年后)为 0.6%,不确定结果者为 3.7%。

结论

既往 CT 肺癌筛查结果为接受肺癌筛查者提供了进一步进行风险分层的机会。

试验注册号

结果,ISRCTN63545820。

相似文献

1
Risk stratification based on screening history: the NELSON lung cancer screening study.基于筛查史的风险分层:NELSON 肺癌筛查研究。
Thorax. 2017 Sep;72(9):819-824. doi: 10.1136/thoraxjnl-2016-209892. Epub 2017 Mar 30.
2
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.低剂量 CT 肺癌筛查中新出现实性结节的发生率和肺癌概率:来自随机、对照 NELSON 试验的数据分析。
Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.
3
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.NELSON 肺癌筛查试验的最终筛查轮次:2.5 年筛查间隔的影响。
Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30.
4
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.通过低剂量 CT 筛查检测肺癌(NELSON):筛查试验性能和间期癌的预设分析。
Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1.
5
Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.计算机断层扫描筛查在随机 NELSON 试验中检测到的肺癌特征。
Am J Respir Crit Care Med. 2013 Apr 15;187(8):848-54. doi: 10.1164/rccm.201209-1651OC.
6
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).筛查试验中基于风险从普通人群中进行选择:荷兰 - 比利时随机肺癌多层CT筛查试验(NELSON)的选择标准、招募及效能
Int J Cancer. 2007 Feb 15;120(4):868-74. doi: 10.1002/ijc.22134.
7
Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.肺癌计算机断层扫描筛查对健康相关生活质量的长期影响:NELSON 试验。
Eur Respir J. 2011 Jul;38(1):154-61. doi: 10.1183/09031936.00123410. Epub 2010 Dec 9.
8
Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.低剂量 CT 肺癌筛查中检出的新发实性结节的特征:NELSON 研究。
Thorax. 2018 Aug;73(8):741-747. doi: 10.1136/thoraxjnl-2017-211376. Epub 2018 Apr 16.
9
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.在 NELSON CT 肺癌筛查研究的发病轮次中持续出现新的结节。
Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.
10
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.CT 检测到肺结节患者的肺癌概率:来自低剂量 CT 筛查 NELSON 试验数据的预设分析。
Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.

引用本文的文献

1
Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer.肺癌中度风险患者的计算机断层扫描筛查间隔
JAMA Netw Open. 2025 Jul 1;8(7):e2523044. doi: 10.1001/jamanetworkopen.2025.23044.
2
Beyond nodules: body composition as a biomarker for future lung cancer.超越结节:身体成分作为未来肺癌的生物标志物
Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11735-6.
3
Lung cancer screening: where do we stand?肺癌筛查:我们目前的状况如何?
Breathe (Sheff). 2024 Aug 27;20(2):230190. doi: 10.1183/20734735.0190-2023. eCollection 2024 Jun.
4
The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations.模型假设对个体化肺癌筛查推荐的影响。
Med Decis Making. 2024 Jul;44(5):497-511. doi: 10.1177/0272989X241249182. Epub 2024 May 13.
5
Influenza season influence on outcome of new nodules in the NELSON study.内尔森研究中,流感季节对新结节转归的影响。
Sci Rep. 2023 Apr 21;13(1):6589. doi: 10.1038/s41598-023-33672-4.
6
[China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2023 Version)].《中国肺癌筛查与早诊早治指南(2023年版)》 [此处根据文本推测可能是指南的全称,原英文表述不完整,推测可能是关于低剂量计算机断层扫描的肺癌筛查指南,具体需结合完整资料确定] (注:因英文原文存在可能信息不完整的情况,此译文可能与实际指南全称不完全匹配,仅根据当前英文内容尽量准确翻译) 说明:因原英文内容疑似不完整,译文括号内为补充推测内容,以便更完整表达可能的意思,实际翻译需结合完整准确的英文原文。
Zhongguo Fei Ai Za Zhi. 2023 Jan 20;26(1):1-9. doi: 10.3779/j.issn.1009-3419.2023.102.10.
7
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描(LDCT)筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
8
LingZhi oligopeptides amino acid sequence analysis and anticancer potency evaluation.灵芝寡肽氨基酸序列分析及抗癌效能评估。
RSC Adv. 2020 Feb 27;10(14):8377-8384. doi: 10.1039/c9ra10400c. eCollection 2020 Feb 24.
9
Participation and Yield of a Lung Cancer Screening Program in Hebei, China.中国河北肺癌筛查项目的参与情况与筛查率
Front Oncol. 2022 Jan 10;11:795528. doi: 10.3389/fonc.2021.795528. eCollection 2021.
10
Lung cancer risk following previous abnormal chest radiographs: A 27-year follow-up study of a Chinese lung screening cohort.先前异常胸部 X 光片后肺癌风险:一项对中国肺癌筛查队列的 27 年随访研究。
Thorac Cancer. 2021 Dec;12(24):3387-3395. doi: 10.1111/1759-7714.14213. Epub 2021 Nov 9.